Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer Farhat Nasim22 April 2019 4:00 AM GMTNew Delhi: Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (USFDA) has approved...
FDA expands approval for Pfizer cancer drug Studnt Ruby Khatun Khatun20 Nov 2017 4:37 AM GMTThe U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
Bristol-Myers stops kidney cancer drug test after early success Ruby Khatun Khatun11 Sep 2017 5:18 AM GMTBristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end...